A Survey of Greek Primary Care Physicians on Their Likeability in Treating Migraines and Other Common Diseases.

: Migraine is considered the most clinically important primary headache due to its high prevalence and significant burden. Although globally categorized as one of the leading causes of disability, it is still largely underdiagnosed and undertreated. Worldwide, migraine care is in most cases provided by primary care physicians.

Investigating predictors of well-being in type 2 diabetes mellitus patients: the role of undiagnosed depression.

Type 2 diabetes mellitus (T2DM) is a common metabolic disorder with various medical and psychological adverse effects. Well-being in patients with T2DM is often compromised. The aim of the present study was to investigate clinicodemographic predictors of well-being in patients with T2DM with no known psychiatric history and explore the mediatory role of undiagnosed anxiety and depression.

Attitudes of primary care providers on early palliative care, in new community settings of Attica, Greece; a qualitative analysis.

Background: Early provision of palliative care globally can be achieved by primary health professionals. In Greece, a primary care reformation is currently under development; novel community units have been introduced, with the family physician working for the first time with an interdisciplinary team.

Objectives/setting: To explore the attitudes of such providers, on early palliative care in Attica.

Corrigendum: ACTIVATE-2: A double-blind randomized trial of BCG vaccination against COVID-19 in individuals at risk.

[This corrects the article DOI: 10.3389/fimmu.2022.

ACTIVATE-2: A Double-Blind Randomized Trial of BCG Vaccination Against COVID-19 in Individuals at Risk.

In a recent study of our group with the acronym ACTIVATE, Bacillus Calmete-Guérin (BCG) vaccination reduced the occurrence of new infections compared to placebo vaccination in the elderly. Most benefit was found for respiratory infections. The ACTIVATE-2 study was launched to assess the efficacy of BCG vaccination against coronavirus disease 2019 (COVID-19).